Elimination of pharmaceutical compounds from municipal wastewater by photocatalysis, microfiltration and nanofiltration

• Autorzy: Kudlek E. , Bohdziewicz J. , Dudziak M.
• Języki publikacji: EN

Abstrakty

EN

The aim of the study was to develop an innovative method for the removal of selected pharmaceuticals from biologically treated municipal wastewater. The photocatalytic oxidation in the presence of TiO₂ was carried out in a reactor irradiated with a UV lamp (power 150 W) and two-stage membrane filtration was also applied. In the first stage the catalyst particles were separated using a microfiltration membrane. In the second stage the wastewater was polished in a semi-industrial installation equipped with a flow-through tubular membrane module with a filter surface area of 240 cm². The system combining photocatalysis and membrane filtration allowed for complete elimination of the pharmaceuticals.

Słowa kluczowe

EN

pharmaceuticals; sequential system; photocatalysis; microfiltration; nanofiltration

PL

farmaceutyki; układ sekwencyjny; fotokataliza; mikrofiltracja; nanofiltracja

• Wydawca: Centrum Badań i Innowacji Pro-Akademia ; Ukrainian Academy of Sciences - Research and Development Centre for Industrial Problems of Development
• Czasopismo: Acta Innovations
• Rocznik: 2015
• Tom: no. 16
• Strony: 12--19
• Opis fizyczny: Bibliogr. 19 poz.

Twórcy

autor

Kudlek E.

• Silesian University of Technology, Institute of Water and Wastewater Engineering, 18 Konarskiego str., 44-100 Gliwice, Poland

autor

Bohdziewicz J.

• Silesian University of Technology, Institute of Water and Wastewater Engineering, 18 Konarskiego str., 44-100 Gliwice, Poland

autor

Dudziak M.

• Silesian University of Technology, Institute of Water and Wastewater Engineering, 18 Konarskiego str., 44-100 Gliwice, Poland

Bibliografia

• [1] L.H.M.L.M. Santos, A.N. Araújo, A. Fachini, A. Pena, C. Delerue-Matos, M.C.B.S.M. Montenegro, Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment, J. Hazard. Mater. 175 (2010) 45-95.
• [2] N.M. Vieno, H.Härkki, T. Tuhkanen, L. Kronberg, Occurrence of pharmaceuticals in river water and their elimination in a pilot-scale drinking water treatment plant, Environ. Sci. Technol. 41 (2007) 5077-5084.
• [3] J.L. Santos, I. Aparicio, E. Alonso, Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain), Environ. Inter., 33 (2010) 596-601.
• [4] Directive 2013/39/EU of the European Parliament and of the Council of 12 August 2013 amending Directives 2000/60/EC and 2008/105/EC as regards priority substances in the field of water policy (Dz. Urz. L 226 z 24.8.2013, s.1).
• [5] Commission Implementing Decision (EU) 2015/495 of 20 march 2015 establishing a watch list of substances for Union-wide monitoring in the field of water policy pursuant to Directive 2008/105/EC of the European Parliament and of the Council (Dz.U.UE.L.2015.78.40).
• [6] R. Triebskorn, H. Casper, A. Heyd, R. Eikemper, H.R. Kohler, J. Schwaiger, Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part II. Cytological effects in liver, kidney, gills and intestine of rainbow trout, Aquat. Toxicol., 68 (2004) 151-166.
• [7] B. Hoeger, B. Kollner, D.R. Dietrich, B. Hitzfeld, Water-borne diclofenac affects kidney and gill integrity and selected immune parameters in brown trout (Salmo trutta f. fario), Aquat. Toxicol., 75 (2005) 53-64.
• [8] F. Pomati, A.G. Netting, D. Calmari, B.A. Neilan, Effects of erythromycin, tetraycline and ibuprofen on the growth of Synechocysts sp. and Lemna minor, Aquat. Toxicol., 67 (2004) 387-396.
• [9] C. Miège, J.M. Choubert, L. Ribeiro, M. Eusèbe, M. Coquery, Fate of pharmaceuticals and personal care products in wastewater treatment plants. Conception of a database and first results, Environ. Poll., 157 (2009) 1721-1726.
• [10] A. Jelic, M. Gros, A. Ginebreda, R. Cespedes-Sánchez, F. Ventura, M. Petrovic , D. Barcelo, Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment, Water Res. 45 (2011) 1165-1176.
• [11] N.A. Doerr-MacEwen, M.E. Haight, Expert stakeholders' views on the management of human pharmaceuticals in the environment, Environ Manage. 38(2006) 853-866.
• [12] A. Rey, J. Carbajo, C. Adán, M. Faraldos, A. Bahamonde, J.A. Casas, J.J. Rodriguez, Improved mineralization by combined advanced oxidation processes, Chem. Eng. J. 174 (2011) 134-142.
• [13] L. Feng, E.D. van Hullebusch, M.A. Rodrigo, G. Esposito, M.A. Oturan, Removal of residual anti- inflammatory and analgesic pharmaceuticals from aqueous systems by electrochemical advanced oxidation processes. A review, Chem. Eng. J. 228 ( 2013) 944-964.
• [14] J.-C. Sin, S.-M. Lam, A.R. Mohamed, K.-T. Lee, Degrading Endocrine Disrupting Chemicals from Wastewater by Photocatalysis: A Review, International Journal of Photoenergy 2012 (2012) 1-23.
• [15] H. Ozaki, N. Ikejima, Y. Shimizu, K. Fukami, S. Taniguchi, R. Takanami, R.R. Giri, S. Matsui, Rejection of pharmaceuticals and personal care products (PPCPs) and endocrine disrupting chemicals (EDCs) by low pressure reverse osmosis membranes, Water Sci. Technol., 58 (2008) 73-81.
• [16] A. Simon, L.D. Nghiem, P. Le-Clech, S.J. Khan, J.E. Drewes, Effects of membrane degradation on the removal of pharmaceutically active compounds (PhACs) by NF/RO filtration processes, J. Membr. Sci., 340 (2009) 16-25.
• [17] M. Dudziak, Separacja mikrozanieczyszczeń estrogenicznych wysokociśnieniowymi technikami membranowymi, Wydaw. Politechniki Śląskiej, Gliwice, 2013. (in Polish).
• [18] J. Bohdziewicz, E. Kudlek, M. Dudziak, Influence of the catalyst type (TiO2 and ZnO) on the photocatalytic oxidation of pharmaceuticals in the aquatic environment, Des. Wat. Treat. (in press).
• [19] D. Suryaman, K. Hasegawa, S. Kagaya, T. Yoshimura, Continuous mineralization of concentrated phenol dissolved in an electrolyte-containing tap water by integrating biological-photocatalytic treatment with TiO2 separation: utilization of sunlight and reuse of TiO2, Environ. Technol., 30 (2009) 215-224.

Uwagi

Opracowanie rekordu w ramach umowy 509/P-DUN/2018 ze środków MNiSW przeznaczonych na działalność upowszechniającą naukę (2018).